版本:
中国

BRIEF-Sierra Oncology granted U.S, EU patents for Chk1 inhibitor SRA737

May 30 Sierra Oncology Inc:

* Sierra Oncology granted US and EU patents for Chk1 inhibitor SRA737

* Sierra Oncology Inc - selection patent issued for sra737 covers compound explicitly and extends initial protection out to 2033 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐